Activation of the mTOR Signaling Pathway in Renal Clear Cell Carcinoma-Reference-Cited by-同舟云学术

Activation of the mTOR Signaling Pathway in Renal Clear Cell Carcinoma

Published:2007-01 Issue:1 Volume:177 Page:346-352
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Robb Victoria A.¹,Karbowniczek Magdalena¹,Klein-Szanto Andres J.¹,Henske Elizabeth P.¹

Affiliation:

1. Fox Chase Cancer Center, Philadelphia, Pennsylvania

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma;Burczynski;Clin Cancer Res,2005

2. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer;Raymond;J Clin Oncol,2004

3. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma;Atkins;J Clin Oncol,2004

4. Mutations of the VHL tumour suppressor gene in renal carcinoma;Gnarra;Nat Genet,1994

5. Rheb binds and regulates the mTOR kinase;Long;Curr Biol,2005

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics;Diagnostics;2024-08-29

2. Unconventional mechanism of action and resistance to rapalogs in renal cancer;Proceedings of the National Academy of Sciences;2024-06-11

3. Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma;International Journal of Molecular Sciences;2023-03-29

4. Clear Cell Renal Cell Carcinoma: From Biology to Treatment;Cancers;2023-01-21

5. DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer;Technology in Cancer Research & Treatment;2023-01